Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP604412.RADe86N_1nq9e9veWWY2DfdlI5CJMm37a60na4ClZ-Iks130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP604412.RADe86N_1nq9e9veWWY2DfdlI5CJMm37a60na4ClZ-Iks130_assertion type Assertion NP604412.RADe86N_1nq9e9veWWY2DfdlI5CJMm37a60na4ClZ-Iks130_head.
- NP604412.RADe86N_1nq9e9veWWY2DfdlI5CJMm37a60na4ClZ-Iks130_assertion wasGeneratedBy ECO_0000203 NP604412.RADe86N_1nq9e9veWWY2DfdlI5CJMm37a60na4ClZ-Iks130_provenance.
- NP604412.RADe86N_1nq9e9veWWY2DfdlI5CJMm37a60na4ClZ-Iks130_assertion wasDerivedFrom befree-20140225 NP604412.RADe86N_1nq9e9veWWY2DfdlI5CJMm37a60na4ClZ-Iks130_provenance.
- NP604412.RADe86N_1nq9e9veWWY2DfdlI5CJMm37a60na4ClZ-Iks130_assertion SIO_000772 12477769 NP604412.RADe86N_1nq9e9veWWY2DfdlI5CJMm37a60na4ClZ-Iks130_provenance.
- NP604412.RADe86N_1nq9e9veWWY2DfdlI5CJMm37a60na4ClZ-Iks130_assertion evidence source_evidence_literature NP604412.RADe86N_1nq9e9veWWY2DfdlI5CJMm37a60na4ClZ-Iks130_provenance.
- NP604412.RADe86N_1nq9e9veWWY2DfdlI5CJMm37a60na4ClZ-Iks130_assertion description "[Postoperatively, serum mutant KRAS2 is a strong predictor of disease recurrence, stronger even than Dukes' stage of disease, and thus shows potential for use in clinical practice as a marker of preclinical disease recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP604412.RADe86N_1nq9e9veWWY2DfdlI5CJMm37a60na4ClZ-Iks130_provenance.